<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In addition to hepatocellular <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, HFE C282Y homozygotes are reported to have increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This study was done to further explore the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in C282Y homozygotes </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIAL AND METHODS: We studied <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence in 292 homozygotes and 62,568 others that participated in the HUNT 2 population screening in 1995-1997 </plain></SENT>
<SENT sid="3" pm="."><plain>Using Cox proportional hazard models, we estimated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> hazard ratio as a function of C282Y homozygosity and several screening variables including serum transferrin saturation, alcohol consumption and daily smoking </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> was diagnosed in 36 homozygotes, five of which had two <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnoses </plain></SENT>
<SENT sid="5" pm="."><plain>The overall <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence was not increased in C282Y homozygotes (hazard ratio 1.10 [95% CI 0.60-2.03] in women and 0.94 [95% CI 0.53-1.66] in men) </plain></SENT>
<SENT sid="6" pm="."><plain>However, homozygous men had increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (hazard ratio 3.03 [95% CI 1.17-7.82], p = 0.022) and primary <z:hpo ids='HP_0002896'>liver cancer</z:hpo> (hazard ratio 54.0 [95% CI 2.68-1089], p = 0.009) </plain></SENT>
<SENT sid="7" pm="."><plain>The risk of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> in homozygous women was not increased (hazard ratio 1.13 [95% CI 0.35-3.72]) </plain></SENT>
<SENT sid="8" pm="."><plain>Adjusted for other variables including C282Y homozygosity, very low and very high serum transferrin saturation were associated with increased overall <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: C282Y homozygosity is associated with increased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and hepatocellular <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in men </plain></SENT>
<SENT sid="10" pm="."><plain>In the general population, individuals with a very low or a very high serum transferrin saturation may have increased <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
</text></document>